Sanofi Stock Euronext Paris
Stocks
SANNV
FR001400M6Z3
Pharmaceuticals
OTC Markets Traded| Market Cap | 100B 112B 91.69B 83.7B 158B 10,515B 163B 1,105B 441B 5,611B 420B 411B 17,712B | P/E 2026 * |
13.2x | P/E 2027 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 112B 125B 102B 93.41B 176B 11,735B 182B 1,233B 492B 6,262B 469B 459B 19,768B | EV / Sales 2026 * |
2.29x | EV / Sales 2027 * | 2.1x |
| Free-Float |
88.8% | Yield 2026 * |
5.09% | Yield 2027 * | 5.37% |
Last Transcript: Sanofi
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/05/2026 | |
| Director of Finance/CFO | 64 | 01/04/2024 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 56 | 28/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 28/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 112B | |
| +3.44% | -0.80% | +44.81% | +136.72% | 1,206B | |
| +0.98% | +2.68% | +47.46% | +88.45% | 665B | |
| -0.02% | +0.70% | +32.99% | +110.71% | 515B | |
| +2.81% | +0.88% | +43.67% | +68.29% | 381B | |
| +0.64% | -0.76% | +69.72% | +43.81% | 362B | |
| +0.45% | +1.43% | +30.53% | +58.24% | 307B | |
| +1.30% | +1.52% | +7.19% | +34.82% | 289B | |
| +0.08% | -1.38% | +41.82% | +73.83% | 249B | |
| +1.41% | -1.05% | +42.66% | +124.79% | 207B | |
| Average | +1.10% | -1.54% | +40.09% | +82.19% | 464.42B | |
| Weighted average by Cap. | +1.60% | -1.96% | +41.89% | +94.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 48.91B 54.54B 44.7B 40.81B 76.88B 5,126B 79.31B 539B 215B 2,735B 205B 200B 8,635B | 51.53B 57.46B 47.1B 42.99B 81B 5,401B 83.55B 568B 226B 2,882B 216B 211B 9,098B |
| Net income | 7.83B 8.73B 7.16B 6.53B 12.31B 821B 12.7B 86.26B 34.4B 438B 32.77B 32.07B 1,382B | 9.26B 10.32B 8.46B 7.72B 14.55B 970B 15.01B 102B 40.67B 518B 38.75B 37.92B 1,635B |
| Net Debt | 11.64B 12.98B 10.64B 9.71B 18.3B 1,220B 18.88B 128B 51.14B 651B 48.73B 47.68B 2,056B | 7.92B 8.83B 7.24B 6.61B 12.45B 830B 12.84B 87.26B 34.79B 443B 33.15B 32.44B 1,398B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
